Director of quality assurance for CCE
Active Purchase Order Awarded Last action
- Contract number
- 75N90026P00081
- Awardee
-
Propharma Group LLC UEI N6C8UMMHCB15
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $415,594
Award facts
- Contract value 100% obligated
- $415,593.72 Current and potential, with all options
- Completion date 74% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
The National Institutes of Health Clinical Center awarded a purchase order valued at $415,593.72 to Propharma Group LLC (doing business as Acadeus) for a Director of Quality Assurance position supporting the Center for Clinical Excellence (CCE). This firm fixed-price contract, which was not set aside for any specific business category, runs through January 30, 2027, with the place of performance located in Bethesda, Maryland. Propharma Group LLC is a for-profit Subchapter S Corporation and research consulting organization that specializes in expert consulting services for federal healthcare and medical research agencies, with particular expertise in regulatory sciences, clinical research, quality assurance, and pharmacovigilance.
The contractor brings extensive experience supporting the NIH Clinical Center through multiple Blanket Purchase Agreement call contracts under the General Services Administration's Multiple Award Schedule, with previous engagements encompassing quality unit reorganization, investigational drug management, regulatory compliance, and operational support for research programs. In addition to its work with NIH, Propharma Group holds a significant $25 million Indefinite Delivery/Indefinite Quantity contract with the Food and Drug Administration for the review of laboratory-developed tests and in vitro diagnostics, positioning the firm as an established provider of specialized scientific and regulatory review services across multiple federal health agencies.
Quick answers
Who was awarded contract 75N90026P00081?
75N90026P00081 was awarded to Propharma Group LLC by NIH Clinical Center (National Institutes of Health) on January 31, 2026.
How much is contract 75N90026P00081 worth?
The government has obligated $415,594 on 75N90026P00081.
Was contract 75N90026P00081 competed?
The extent of competition for 75N90026P00081 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award